Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEAST: Low-dose Aspirin After STEMI
NCT06756945Phase 4Not yet recruiting
- Sponsor
- Beijing An Zhen Hospital
- Start
- Jan 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of aspirin in ST elevation myocardial infarction (STEMI), sponsored by Beijing An Zhen Hospital. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT06756945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06756945.